Argenx Acquires Forte Biosciences in $2.2 Billion Deal

Argenx has agreed to acquire Forte Biosciences for $2.2 billion, a move aimed at strengthening its pipeline of autoimmune drugs with the addition of FB102.

Post Share

Sources

Showing 0 of 2 sources

No articles available in your preferred languages.

2 articles available in other languages below.

YahooDanish2d ago

argenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102

Read full article →

seeking-alphanob2d ago

argenx strikes $2.2B deal for Forte Biosciences

Read full article →

Coverage Timeline

First report: seeking-alpha · 27 Jul, 08:20|Full coverage: 2 · 6h|Window: 6h

Left-leaningCenterRight-leaning

seeking-alpha27 Jul, 08:20First to report

argenx strikes $2.2B deal for Forte Biosciences

6h later

Yahoo27 Jul, 14:01Latest update

PERSPECTA

PERSPECTA

Argenx Acquires Forte Biosciences in $2.2 Billion Deal

Sources

argenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102

argenx strikes $2.2B deal for Forte Biosciences

Coverage Timeline

argenx strikes $2.2B deal for Forte Biosciences

argenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102

Related Stories

Manila Water Launches August Desludging Program

Philippines' DOE to Establish Energy Center for Excellence

Philippine BIR sues Pogo-linked firm for tax evasion

Marcos Administration Pushes for Income Tax Relief and Agrarian Reform

PERSPECTA